The outlook for mRNA vaccines and therapeutics continues to be promising, with demand expected to increase as many candidates move into late-stage clinical development and on toward commercialization. With […]
With over 50 years of experience, we are a forward-thinking,
North American CDMO specializing in clinical-to-commercial scale production of high-quality regulated APIs and Intermediates.
SEO plus – Test
- 20+ years at GSK, leading R&D activities on multiple vaccine programs
- Recently held positions in industry include: Senior Director (Function Head), Protein Biochemistry; Director, Antigen Design & Prototype Production; and, Associate Director, Antigen Design and Protein Characterization.
- Key areas of expertise are:
- Process development of protein Biologics/Recombinant Antigens
- Recombinant protein expression (mammalian, insect, yeast, bacterial)
- Production/design of Viral Vectors, mRNA vaccines, Bacterial outer membrane vesicles
- Protein Engineering and Structural Biology
- Defining quality attributes, biophysical characterization of proteins, and analytical strategy
- Post graduate degrees in Functional Genomics (Université Laval) and Bioinformatics (MIT); M. Sc. Microbiology and Immunology (Laval).
- 25+ Patent & 5 Scientific Publications